Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Xue Ying Ren"'
Autor:
Ming-Wei Ma, Hong-Zhen Li, Xian-Shu Gao, Ming-Zhu Liu, Huan Yin, Kai-Wei Yang, Jia-Yan Chen, Xue-Ying Ren, Dian Wang
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7832-7841 (2022)
Background: Stereotactic ablative body radiotherapy (SABR) is one of the treatment options for oligometastatic renal cell carcinoma (RCC) but is limited by a lack of data to evaluate high-dose SABR to all/multiple sites. Objective: This study retrosp
Externí odkaz:
https://doaj.org/article/c032ef249fbd4353972f6ddf744c4214
Publikováno v:
Diagnostics, Vol 13, Iss 21, p 3350 (2023)
Prostate cancer (PCa) is a widespread malignancy with global significance, which substantially affects cancer-related mortality. Its spectrum varies widely, from slow-progressing cases to aggressive or even lethal forms. Effective patient stratificat
Externí odkaz:
https://doaj.org/article/65055311ad484386aed66edced0131f1
Autor:
Feng Lyu, Shi-Yu Shang, Xian-Shu Gao, Ming-Wei Ma, Mu Xie, Xue-Ying Ren, Ming-Zhu Liu, Jia-Yan Chen, Shan-Shi Li, Lei Huang
Publikováno v:
Biomedicines, Vol 11, Iss 6, p 1628 (2023)
Prostate cancer (PCa) is a critical global public health issue with its incidence on the rise. Radiation therapy holds a primary role in PCa treatment; however, radiation resistance has become increasingly challenging as we uncover more about PCa’s
Externí odkaz:
https://doaj.org/article/df14e20203ac487fa80ded583577d33c
Autor:
Mu Xie, Xian-Shu Gao, Ming-Wei Ma, Xiao-Bin Gu, Hong-Zhen Li, Feng Lyu, Yun Bai, Jia-Yan Chen, Xue-Ying Ren, Ming-Zhu Liu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundIt is not known which risk stratification system has the best discrimination ability for predicting prostate cancer death.MethodsWe identified patients with non-metastatic primary prostate adenocarcinoma diagnosis between 2004 and 2015 usin
Externí odkaz:
https://doaj.org/article/64e7791e04224d30b147c19380605db0
Autor:
Chao-Yang Wang, Peng Wang, Huifen Fu, Chong-Chen Wang, Xue-Ying Ren, Xiu-Wu Zhang, Baoyi Yu, Zi-Xuan Zhao
Publikováno v:
Chinese Chemical Letters. 33:1353-1357
Development of new self-calibrating fluorescent sensing methods has been a popular research field with the aim of protecting the human health and environment sustainability. In this work, a novel Eu-based metal organic framework (MOF) Eu(2,6-NDC)(COO
Autor:
Xin Qi, Xian-Shu Gao, Xiao-mei Li, Shang-bin Qin, Xiao-ying Li, Ming-wei Ma, Yun Bai, Jia-yan Chen, Xue-ying Ren, Hong-zhen Li
Purpose It is indicated by prostatectomy specimens that the proximal 1- to 2-cm seminal vesicles (SVs) be irradiated in radiotherapy for prostate cancer with intermediate- to high-risk factors. However, patients usually receive neo-adjuvant hormonal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2478428a7567dbee93b2035ebc7386a8
https://doi.org/10.21203/rs.3.rs-2343333/v1
https://doi.org/10.21203/rs.3.rs-2343333/v1
Autor:
Siwei Liu, Peng Kang He, Jing Zhou, Bo Zhao, Xian Shu Gao, Ming Wei Ma, Shang Bin Qin, Xue Ying Ren, Yi Rong, Zhi Lei Zhao, Kang Li, Yun Bai
Publikováno v:
Journal of Applied Clinical Medical Physics
Purpose To evaluate dosimetric properties of intensity‐modulated proton therapy (IMPT) for simulated treatment planning in patients with atrial fibrillation (AF) targeting left atrial‐pulmonary vein junction (LA‐PVJ), in comparison with volumet
Publikováno v:
Revista da Associação Médica Brasileira, Vol 66, Iss 7, Pp 948-953 (2020)
Revista da Associação Médica Brasileira v.66 n.7 2020
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira v.66 n.7 2020
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
SUMMARY OBJECTIVE Long noncoding RNAs (lncRNAs) have been shown to play a critical role in tumor progression. Abnormal expression of LncRNA PTPRG antisense RNA 1 (PTPRG-AS1) has been reported in several tumors. Hence, we aimed to determine the expres
Autor:
Hongzhen Li, Jia-yan Chen, Xue-Ying Ren, Ming-Wei Ma, Ming-Zhu Liu, Yun Bai, Xiao-Bin Gu, Mu Xie, Feng Lyu, Xianshu Gao
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundIt is not known which risk stratification system has the best discrimination ability for predicting prostate cancer death.MethodsWe identified patients with non-metastatic primary prostate adenocarcinoma diagnosis between 2004 and 2015 usin
Autor:
Zhilei Zhao, Xuanfeng Ding, Xin Qi, Siwei Liu, S. Qin, Jia-yan Chen, Xiaoying Li, Xue-Ying Ren, Bo Zhao, Mu Xie, Gao Xianshu, Yun Bai, Mingwei Ma
Purpose: Increased volume ratio of Biologic Effective Dose (BED) was associated with higher local control rate in a setting of large (greater than 5 cm) non-small cell lung cancer (NSCLC) via photon partial stereotactic ablative boost radiotherapy (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dc1ef7e65272aa8f12355f7242b3e5a
https://doi.org/10.21203/rs.3.rs-92220/v1
https://doi.org/10.21203/rs.3.rs-92220/v1